Rheumatoid arthritis (RA) is a multifactorial disease that can be initiated by the combination of environmental and genetic factors. RA is one of the most highly prevalent autoimmune diseases; nearly 1% of the world's population have the condition 1 . During RA, dysregulation of the immune system leads to persistent synovial inflammation, cellular infiltration and proinflammatory cytokine production, as well as progressive deformation and/or destruction of cartilage and bone in the joint. Ultimately, these events can result in chronic pain, severe disability and increased mortality. Whereas lymphocytes are necessary for the initiation of RA 2 , professional phagocytic cells of the innate immune system, including macrophages and dendritic cells (DCs), are also emerging as important cell populations in the pathogenesis of this debilitating disease.
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. During RA, dysregulation of the immune system leads to persistent synovial inflammation, cellular infiltration and proinflammatory cytokine production, as well as progressive deformation and/or destruction of cartilage and bone in the joint. Ultimately, these events can result in chronic pain, severe disability and increased mortality. Whereas lymphocytes are necessary for the initiation of RA 2 , professional phagocytic cells of the innate immune system, including macrophages and dendritic cells (DCs), are also emerging as important cell populations in the pathogenesis of this debilitating disease.
Although macrophages and DCs can arise from a common progenitor and share a variety of roles, including antigen presentation, participation in T-cell homeostasis and maintenance of gut immunity, they also maintain distinct functionality within the immune system and in the context of disease [3] [4] [5] . Over the past 20 years, synovial macrophages have been recognized to be crucial for the persistence of RA 6 . Circulating monocytes in peripheral blood -classically activated monocytes in particular -are increased in patients with RA 7 . These classically activated monocytes migrate to the joint and differentiate into macrophages, thereby leading to increased macrophage numbers, which correlate with articular destruction 8, 9 . In RA, macrophages are highly activated, express increased levels of Toll-like receptors (TLRs), such as TLR2, TLR3, TLR4 and TLR7, and contribute to synovial inflammation and destruction of cartilage and bone through the production of degradative enzymes, cytokines and chemokines 6, [10] [11] [12] [13] . Approved therapeutics, including anakinra and etanercept (which target IL-1β and TNF, respectively), decrease inflammation, bone destruction and macrophage numbers in the synovial sublining [14] [15] [16] . Furthermore, a reduced number of macrophages in the synovial sublining correlates with better outcomes in RA and serves as a biomarker to determine the efficacy of a particular therapy 17, 18 . Phagocytes respond to molecules released by and/or exposed on cells undergoing apoptosis to either suppress or elicit an inflammatory response 19 . Under homeostatic conditions, professional phagocytes (macrophages and immature DCs), non-professional phagocytes (epithelial cells and fibroblasts) and specialized phagocytes (Sertoli cells and retinal pigment epithelial cells) mediate the removal of apoptotic cells depending on the environmental context 19 . Engulfment of apoptotic cells by phagocytes (phagocytosis) occurs in a step-wise fashion. First, the apoptotic cell releases 'find-me' signals that attract, and potentially activate, phagocytes 19 . The phagocyte must then distinguish the apoptotic cell from surrounding healthy cells through engulfment receptors, including scavenger receptors (such as CD36) and tyrosine kinases (such as MerTK), that recognize 'eat-me' signals (for example, plasma membrane lipid phosphatidylserine) on the apoptotic cell 19 . Subsequently, extensive rearrangement of the phagocyte's cytoskeleton enables the internalization of the apoptotic cell 19 . The last step involves the processing of the ingested material, which causes the phagocyte to release anti-inflammatory mediators that assist in the dampening of local inflammation 19 . The central mechanism for cell clearance is controlled by the programmed cell death machinery. Failure to clear apoptotic cells can induce tissue inflammation caused by the release of cellular contents and/or exposure to sequestered components, which subsequently engage receptors for damage-associated molecular patterns (DAMPs). The activation of DAMPs might lead to immune responses to self-antigens or autoimmune conditions such as RA 19 . Interestingly, administration of early-stage dying cells reduces disease severity in murine models of inflammation, probably through the induction of anti-inflammatory mediators 20 .
Professional phagocyte populations in RA Macrophages and DCs are vital to the pathogenesis of RA, thus underscoring the necessity of delving further into their functionality within the arthritic joint.
Macrophages
Depending on the microenvironment, activated monocytes can differentiate into two main macrophage subtypes: classically activated (M1 macrophages) and alternatively activated (M2 macrophages). M2 macrophages can be further categorized into different subsets according to the applied stimuli and the consequent transcriptional alterations 21, 22 . Studies within the past decade suggest that mouse macrophages stimulated with IFNγ, LPS and granulocyte-macrophage colony stimulating factor (GM-CSF) become classically activated (M1 macrophages). M1 activation results in the induction of proinflammatory cytokines including TNF, IL-1β, IL-12, IL-18 and IL-23; production of nitric oxide (NO) and reactive oxygen species; antigen presentation; expression of CC chemokine receptors CCR1 and CCR5; promotion of T helper type 1 (T H 1) and T helper type 17 (T H 17) responses. These changes provide an effective mechanism for pathogen killing 22 . Murine macrophages are skewed towards an M2 phenotype by fungal cells, immune complexes, parasites, complement components, apoptotic cells, macrophage colony-stimulating factor (M-CSF), IL-4, IL-13, IL-10, and TGFβ, and can be subdivided into four groups (M2 a-d) depending on the stimuli 22 . Mouse M2 macrophages produce IL-10, arginase 1, chitinase-like protein 3 (also known as Ym1), resistin-like-α (also known as RELMα), and express CD206 and CCR3. These proteins in combination promote pathogen defense, phagocytosis, extra cellular matrix production, apoptotic cell clearance, wound healing and/or anti-inflammatory activities 22 . However, macrophages have been found to exhibit phenotypic plasticity 23, 24 . Changes in the environmental milieu can promote crossover between each group, allowing for an extensive variation in their phenotype 23, 24 . Within only the past 3 years the M1-M2 paradigm has been recognized as a set of well-defined molecular events that are highly reproducible under controlled conditions in vitro, but that have little to no relevance in vivo [25] [26] [27] . Thus, in vivo, populations of macrophages can share both M1-like and M2-like characteristics.
The origin of synovial macrophages is still enigmatic. Bone marrow-derived monocytes were originally identified as precursors of tissue-resident macrophages, including synovial macrophages [28] [29] [30] . However, later studies have shown that many tissue-resident macrophages, such as microglia in the brain, alveolar macrophages in the lung and Kupffer cells in the liver, originate from yolk sac or fetal liver progenitors [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] . Importantly, these tissue-resident macrophages are long-lived and able to maintain homeostasis via in situ proliferation, without the recruitment of circulating monocytes [41] [42] [43] . However, some tissues, such as skin and gut, contain monocyte-derived cells under steady-state conditions, whereas recruitment of monocyte-derived macrophages to other organs (for instance, the lungs, the peritoneal cavity or the spleen) is a hallmark of inflammation 31, 44 . Nonetheless, the role of the apoptotic pathway in the homeostasis of macrophages remains unknown.
We have shown that the mouse and human synovium contains a heterogeneous population of macrophages 45 . More specifically, the mouse joint contains two major populations of macrophages that can be distinguished on the basis of the expression of MHC II. In the context of the inflamed mouse joint, tissue-resident MHC II-negative synovial macrophages possess a high phagocytic capacity and help maintain joint integrity 45 . This
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Efferocytosis
A process similar to, yet distinct from, phagocytosis, whereby phagocytes engulf and eliminate apoptotic cells to promote the resolution of inflammation.
function suggests that inefficient repair of damaged joints by this macrophage population potentially has a vital role in propagating chronic arthritis. In the serum transfer-induced arthritis model (described in BOX 1) , classically activated proinflammatory M1-like macrophages, derived from monocytes recruited to the joint, switch their phenotype towards a more wound-healing M2-like phenotype independently of further monocyte recruitment 45 . Moreover, this switch in macrophage identity during the resolution phase of experimental arthritis coincides with upregulation of genes known to be involved in lipid processing and efferocytosis, such as Mertk, CD36, Pparg and Tgm2
45
. In conjunction with the switch in macrophage identity, the number of neutrophils rapidly diminishes during the resolution phase of experimental arthritis 45 . This evidence suggests that dying neutrophils, through an unknown apoptotic pathway, stimulate recruited macrophages to adopt an M2-like wound-healing phenotype 45 . Consistent with this theory, classically activated M1-like macrophages recruited during the early stages of experimental arthritis-mediated inflammation can efficiently clear apoptotic neutrophils 46 . Therefore, defective clearance of neutrophils by synovial macrophages and/or defective macrophage polarization towards the wound-healing phenotype might be key mechanisms leading to propagation of RA, and might be controlled by apoptotic pathways.
Dendritic cells
In RA, DCs contribute to the marked increase of leukocyte infiltration to synovial tissue 47 . DCs might also have a role in the initiation of the disease by producing cytokines and presenting arthritogenic antigens, which together activate autoreactive T cells 48, 49 . Analyses of human RA synovial tissue and murine models of RA indicate that DCs drive the formation of the ectopic lymphoid organs commonly observed in synovial biopsies 50 . Altered expression of FcγRII as well as heightened responses to TLR2 and TLR4 activation are observed in DCs from patients with high levels of RA disease activity 51, 52 . A clear type I interferon signature is detected in a substantial portion of patients with RA, implicating plasmacytoid DCs in RA pathogenesis, as this population is a major producer of type I interferon 53, 54 . Furthermore, decreased circulating DCs in patients with RA suggest that plasmacytoid and myeloid DCs might selectively home to the inflamed joint [55] [56] [57] [58] [59] . This decrease correlates with an enriched population of DCs possessing a high T-cell stimulatory capacity in inflamed synovial tissue [55] [56] [57] [58] [59] .
Phagocytosis of neutrophils in RA
Short-lived cells that infiltrate inflamed tissue, such as neutrophils, must also be removed during the resolution of inflammation 19 . Neutrophils recruited to the site of bacterial infection can die through the formation of neutrophil extracellular traps (NETs) 60 , which consist of nuclear chromatin and histones that facilitate trapping and killing of bacteria. NETs are thought to initiate inflammation, although certain types of NETs are also capable of contributing to the resolution of inflammation 61 . These data suggest a delicate balance between the proinflammatory and anti-inflammatory capacity of apoptotic cells, which is dependent on the stage of cell death 19 . As neutrophils are abundant in the RA synovial fluid, NETs might contribute to the initiation or the perpetuation of inflammatory arthritis through the constant activation of macrophages in the joint. Whereas inefficient clearance of dying cells by phagocytes might contribute to the break of tolerance, leading to the pathogenesis of RA, defects in cell death machinery within phagocytes could also have deleterious downstream effects. Furthermore, inefficient clearance might occur in response to an efficacious therapy that results in synovial cell death. Although the mechanisms underlying RA-associated autoimmunity are not fully elucidated, insufficient apoptosis is known to have a fundamental role in RA pathogenesis 62, 63 .
Cell death pathways in phagocytes
During the past decade, inflammatory functions have been described for molecules that are classically involved in apoptotic and non-apoptotic cell death pathways through the study of both human samples and mouse models (see BOX 1 for descriptions of mouse models of inflammatory arthritis). Below is a discussion of these newly discovered mechanisms associated with cell death signalling mediators with a focus on the phagocytic cell populations of innate immunity in the development of inflammatory arthritis and other rheumatic diseases (TABLE 1) .
Box 1 | Mouse models of inflammatory arthritis
Mouse models of inflammatory arthritis share many characteristics of rheumatoid arthritis (RA) and are vital for understanding the pathogenesis of disease. Two such murine models are the collagen-induced arthritis (CIA) and the K/BxN serum transfer-induced arthritis. CIA is a multi-faceted immunologically-mediated disease involving lymphocytes (especially T helper (T H ) type 17 cells) and inflammatory cells of innate immunity, which infiltrate joint tissue and induce pathology [177] [178] [179] . CIA is initiated by immunization with bovine type II collagen emulsified in complete Freund's adjuvant 180 . Dendritic cells present type II collagen to T cells, leading to the activation of T H cells 180 . T H cells specific for type II collagen provide help B cells to produce antibodies against type II collagen, culminating in the activation of the complement cascade within the joint 180 . Subsequently, the complement system activates endothelial cells, which release chemoattractants that stimulate inflammatory cell migration into the joint 180 . These inflammatory cells are activated through Fcγ receptors to produce cytokines such as TNF and IL-1β, thereby leading to tissue destruction 180 . IL-17 is crucial for the development of CIA 181 , 182 . However, given that clinical trials have shown that suppression of IL-17 is not as beneficial as treatment with TNF or IL-6 blockade 183 , the clinical relevance of the CIA model is now in question.
In contrast to CIA, the K/BxN serum transfer-induced arthritis murine model mimics the effector phase of RA. K/BxN mice, which are the transgene-positive offspring of KRN and NOD mice, develop a severe, spontaneous, symmetric, erosive and chronic arthritis that mimics RA 184 . The K/BxN serum transfer-induced arthritis model relies on the ability of the KRN-derived transgenic T-cell receptor to recognize a ubiquitous self-peptide (glucose-6-phosphoisomerase; G6PI) when presented in the context of the NOD-derived MHC II allele H-2k (A g7 ), which is followed by B-cell activation and production of anti-G6PI antibodies 185 . Arthritis is passively transferred via a single intravenous injection of K/BxN serum. The K/BxN serum transfer-induced arthritis model, which includes initiation, propagation and resolution phases, is advantageous not only because it is easily transferred to most mouse strains, but also because it is not dependent on T cells and B cells; instead, the model relies on innate immune cells to mediate disease [186] [187] [188] [189] [190] . The K/BxN serum transfer-induced arthritis model can be useful in determining the impact of signalling mediators, specifically in cell populations of the innate immune system. 
Glomerulonephritis
Acute inflammation of the kidney, typically caused by an immune response.
Extrinsic pathway of apoptosis in RA
The apoptotic machinery has long been associated with cell fate. Whereas ligation of death receptors triggers cell death pathways, their activation by cognate ligands can also trigger death-independent functions, including cellular proliferation and inflammatory pathways 64 . Apoptosis can occur via two distinct pathways (FIG. 1) . The extrinsic pathway involves transduction of the apoptotic signal after the binding of death receptors, such as Fas, TNF receptor 1 (TNFR1) or TNF-related apoptosis-inducing ligand (TRAIL) receptors 1 and 2, to their respective ligands FasL, TNF and TRAIL. By contrast, the intrinsic pathway signals through the mitochondria and is regulated by the BCL-2 protein family (discussed in the next section). In an example of the extrinsic pathway, binding of the homotrimeric death ligand FasL to its cognate death receptor Fas facilitates the recruitment of the Fas-associated death domain protein (FADD). Subsequently, FADD recruits the inactive form of caspase 8, the aggregation and homodimerization of which result in its autocatalysis and/or activation. This step induces the degradative phase of apoptosis through the activation of caspase 3 and caspase 7, which are coordinators of downstream apoptotic cellular processes 65 . CASP8 and FADD-like apoptosis regulator (also known as FLIP), a catalytically inactive homologue of caspase 8, acts as an endogenous regulator of the Fas pathway at the level of caspase 8 activation. FLIP is recruited by FADD upon Fas activation and can either inhibit or potentiate the binding of FADD and caspase 8, depending on its concentration 66, 67 . An alternative pathway of Fas-induced cell death involves crosstalk between the extrinsic and the intrinsic apoptotic pathways. This crosstalk is mediated by the activation of the BCL-2 pro-apoptotic protein BH3-interacting domain death agonist (also known as BID) 68, 69 , which is cleaved by caspase 8 following Fas ligation. The cleaved form of BID is then targeted to the mitochondria and ultimately induces the intrinsic apoptotic pathway 70 .
In vivo, very few apoptotic cells are generally observed in RA tissues, despite high expression levels of Fas and/or FasL [71] [72] [73] [74] . This evidence indicates that in RA the function of the death receptor Fas is independent of cell death. Other studies have shown that reduced expression of FasL on invading T cells might account for the ineffective clearance of activated Fas-expressing cells 75 . In addition, synovial cell production of pro inflammatory cytokines protects RA synoviocytes and invading T cells from Fas-induced apoptosis [76] [77] [78] . RA synovial fluid contains high levels of NO that can potentially block apoptosis, given that NO inhibits the action of caspase 3, a mediator of the degradative phase of the apoptotic pathway 79 . Taken together, these studies imply that defective Fas signalling contributes to the pathogenesis of RA (TABLE 1) .
Evidence from studies in experimental models implicates the extrinsic pathway of apoptosis in arthritis. Below, we discuss the death receptor Fas and its downstream signalling components in phagocytic cell populations of the innate immune system in these models.
Fas. Mice homozygous for the lpr mutation of the Fas gene display normal postnatal development but, with age, manifest splenomegaly, lymphadenopathy, hypergammaglobulinaemia, autoantibody production, glomerulonephritis and presence of double-negative T cells (CD3   +   CD4 − CD8 − B220 + ). The development of this advanced systemic lupus erythematosus (SLE)-like disease, which can include inflammatory arthritis, is highly dependent on strain background 80 . For example, the auto immuneprone MRL mouse strain with the lpr mutation (MRL. Fas lpr ) not only presents with the most severe SLElike disease, but also spontaneously develops chronic synovitis 81 . The advent of conditional gene deletion has enabled cell-specific dissection of the functions of Fas and its downstream signalling components in haematopoietic cell populations (TABLE 1) . Mice with conditional deletion of Fas in the myeloid cell compartment (LysM cre/cre Fas flox/flox mice), which includes monocytes, macrophages and neutrophils, develop an SLE-like disease characterized by splenomegaly, hypergammaglobulinaemia, glomerulonephritis and production of autoantibodies as well as proinflammatory cytokines 82 . In these mouse mutants, the accumulation of peripheral monocytes, macrophages and granulocytes increases the activation of and disrupts the normal distribution of both DCs and T cells, which indicates that, in myeloid cells, Fas has an indirect role in the activation of other immune cells 82 . TLR activation is a critical step in the activation and functional differentiation of macrophages; therefore, it has a crucial role in the development and persistence of SLE-like disease in mice 83 . Mortality of myeloid cell-specific Fas-knockout mice following a high-dose lipopolysaccharide (LPS) injection is higher than that of control mice 82 . Thus, loss of Fas in myeloid cells results in a heightened systemic reaction to TLR ligation, suggesting that this death receptor not only initiates the extrinsic apoptotic pathway, but also maintains TLR activation.
The C57BL/6 mouse strain carrying the lpr mutation (C57BL/6.Fas lpr ) presents with an exacerbated K/B×N serum transfer-induced arthritis that is characterized by increased inflammation, pannus formation and destruction of bone and cartilage compared with control C57BL/6 mice 84 . Furthermore, although macrophages from C57BL/6.Fas lpr mice are primed for increased cytokine production, mice with the same Fas mutation on the DBA/1 background present with less-severe CIA 85 , which indicates that strain background and choice of arthritis model are critical when functional defects and their effect on arthritis pathogenesis are examined. In contrast to C57BL/6. Fas lpr mice, the onset of K/B×N serum transfer-induced arthritis in young myeloid cell-specific Fas-knockout mice is comparable to that of control mice, although arthritis resolution is accelerated in the chronic phase, as evidenced by the reduction of inflammation and neutrophil infiltration 86 . Consistent with a more rapid resolution of disease, the joints of myeloid cell-specific Fas-knockout mice have higher levels of IL-10, as well as reduced expression of CXCL5 (a neutrophil chemotactic chemokine) and the TLR2 ligand endoplasmin (also known as GRP94) 86 . Furthermore, Fas-deficient macrophages produce higher levels of IL-10 when stimulated in vitro with IL-1β and endoplasmin 86 . These data indicate that Fas signalling in mouse macrophages propagates joint inflammation by decreasing expression of IL-10 and increasing expression of endoplasmin 86 . This mechanism might also be relevant to inflammation in human RA joints. Similarly to myeloid cell-specific Fas-knockout, Fas deficiency in DCs results in systemic autoimmunity 87 . However, whether DC-specific Fas signalling promotes joint inflammation as observed in macrophages remains to be determined. FADD. In the sequence of signalling events, binding of FasL to the death receptor Fas facilitates recruitment of FADD. In severe combined immunodeficient (SCID) mice engrafted with human RA synovium, the local injection of a replication-defective adenovirus expressing FADD induces apoptosis in the synovium and suppresses synoviocyte proliferation 88 . In addition, FADD can sequester MYD88 (an adaptor protein essential for most TLR signalling), thereby hindering the activation of the transcription factor NF-κB. Therefore, the reduction of FADD, or reduced recruitment of FADD to the Fas receptor as occurs in RA, might account for the enhanced NF-κB signalling and the production of pro inflammatory cytokines 85 . Furthermore, in mouse organs cultured in vitro, FADD expression can be regulated by adenosine receptors, which can control FADD secretion through the process of microvesicle shedding 89 . In the synovial fluid of patients with RA, in addition to a high concentration of adenosine, the presence of microvesicles that originate from monocytes, neutrophils and lymphocytes represent another potential source of FADD 90 . These microvesicles can trigger the release of chemokines, cytokines and other inflammatory mediators from synovial fibroblasts 90 . This evidence suggests a link between the regulation of FADD by microvesicle shedding and the perpetuation of RA, as the reduction of intracellular FADD could lead to defective apoptosis and excess proliferation of synovial fibroblasts 91 . Thus, FADD gene transfer or activation of FADD might be effective therapeutic strategies for RA Global deletion of MYD88 has been found to rescue these phenotypes, indicating that the inflammation caused by the loss of FADD is attributable to MYD88 signalling rather than defects in cell death 92 . Another study by the same group also demonstrated that, similarly to myeloid cell-specific FADD-knockout mice, DC-specific FADD deficiency (in CD11c cre FADD flox/flox mice) results in systemic inflammation, higher levels of proinflammatory cytokines and increased numbers of macrophages, neutrophils and In an example of the extrinsic pathway of apoptosis, the binding of Fas ligand (FasL) to its receptor Fas leads to the cleavage and activation of caspase 8. This proteolytic step is mediated by the adaptor protein Fas-associated death domain protein (FADD) and can be inhibited by FADD-like apoptosis regulator (also known as FLIP), a catalytically inactive homologue of caspase 8. Subsequently, caspase 8 cleaves and activates caspase 3 and caspase 7, which in turn induce the degradative phase of apoptosis. In the intrinsic pathway of apoptosis, the BCL-2 homology region 3 (BH3)-only proteins can either sequester anti-apoptotic proteins such as BCL-2, or directly activate the pro-apoptotic multi-BH3 proteins, such as BAK and BAX. Once the apoptotic signalling is initiated, BAK and BAX induce the release of cytochrome c from the mitochondrion. Subsequently, cytochrome c binds to APAF1 and forms a complex with pro-caspase 9 (apoptosome). Activation of caspase 9 in the apoptosome in turn induces apoptosis through the activation of caspase 3 and caspase 7. An alternative pathway of Fas-induced cell death involves crosstalk between the extrinsic and the intrinsic apoptotic pathways. This crosstalk is mediated by the truncated form of BID (tBID), which induces apoptosis by translocating to the mitochondrion.
Proteinuria
The presence of abnormal quantities of proteins in the urine, which might indicate damage to the kidneys.
B cells as compared with control mice. These phenotypes are attributed to the FADD deficiency-induced depletion of CD103 + DCs within gut-associated lymphoid tissues 93 . Chronic inflammation in DC-specific FADD-knockout mice is prevented by global, but not DC-specific, deletion of MYD88 as well as oral antibiotic treatment 93 . Although arthritis has never been examined in the context of myeloid or DC-specific FADD deficiency, this aspect warrants further investigation owing to the potential role of FADD in RA, and the contributions of innate immune cell populations to disease pathogenesis. 65 . FLIP is highly expressed in synovial macrophages of patients with RA and its chemical inhibition with bisindolylmaleimide I within macrophages sensitizes this cell population to Fas-mediated apoptosis [94] [95] [96] [97] . Mice deficient in FLIP in the myeloid cell population (LysM 
FLIP.
The best-characterized mediator of cell death pathways in RA is perhaps FLIP. This protein is recruited by FADD upon Fas activation and can either inhibit or potentiate binding of FADD and caspase 8, according to its concentration
Flip
flox/flox mice) in which FLIP is specifically deleted in monocyte populations 99 . The inability to differentiate ex vivo cultures of FLIP-deficient c-Kit + haematopoietic stem cells into macrophages and the fact that myeloid cell-specific FLIP-deficient mice present with elevated levels of circulating monocytes, yet displayed reduced macrophage numbers in the spleen, lymph nodes and peritoneum, indicate that FLIP is crucial for macrophage differentiation 98 . Although arthritis has not been examined in myeloid cell-specific FLIP-deficient mice, a study published in 2015 reported that targeted deletion of FLIP in both the CD8 + and CD11b − DC compartments of mice (CD11c cre Flip flox/flox mice) promotes the spontaneous development of an erosive inflammatory arthritis that resembles RA and is accompanied by the production of autoantibodies to joint antigens 100 . Before the onset of arthritis, DC populations (in particular CD8 + DCs) are substantially reduced in the thymus, spleen and lymph nodes 100 . Although DC-specific FLIP-knockout mice are lymphopenic, autoreactive CD4 + T cells are detected, suggesting that these cells might participate in the propagation of arthritis 100 . Furthermore, in these mutant mice, reduced numbers of regulatory T (T reg ) cells correlate with the severity of arthritis, and arthritis is ameliorated by the adoptive transfer of T reg cells 100 . In a report by a different research group, mice lacking FLIP in DCs were found to develop neutrophilia (caused by excessive availability of GCSF) and splenomegaly 101 . In contrast to the previous study, the number of peripheral CD11b + , CD8 + and plasmacytoid DCs was not affected; nonetheless, they were hyperactivated as evidenced by increased expression of MHC II, CD80 and CD86 101 . These peripheral DC populations, together with FLIP-deficient bone marrow-derived DCs, are hyperresponsive to stimulation by TLR2, TLR4 and dectin 1 101 . However, this murine model of DC-specific FLIP deficiency does not develop spontaneous arthritis, which might be attributable to either differences in the efficiency of Flip deletion or variability in the colony environment, which can dictate the composition of the gut microbiome [102] [103] [104] . Taken together, these data demonstrate that the role of FLIP in DCs is to reduce the inflammatory response induced by DCs; nonetheless, the underlying mechanism is still unclear.
Caspase 8. FADD also recruits pro-caspase 8, and aggregation and homodimerization of this protease result in autocatalysis and/or activation 65 . A genome-wide association study meta-analysis in >100,000 individuals of European and Asian ancestry (29,880 of whom had RA), evaluated almost 10 million single-nucleotide polymorphisms (SNPs) and revealed a SNP associated with RA risk within the locus that contains the genes encoding caspase 8 and FLIP 105 . Whereas the prospective link between RA risk and FLIP action in DCs has been described, the association between caspase 8 and RA remains a mystery. Despite the role of caspase 8 in cell death being well-established, mounting evidence implicates this protein in death-independent activities, including motility 106 , metastasis 107 , suppression of inflammation 108, 109 , NF-κB activation 110 and interferon regulatory factor (IRF) 3 degradation 108, 111 . Specific deletion of caspase 8 in myeloid cells (LysM cre/cre Casp8 flox/flox mice) leads to the development of a mild systemic inflammation, which is characterized by splenomegaly, lymphadenopathy, deposition of immune complexes in the kidney, proteinuria, hypergammaglobulinaemia and elevated amounts of serum cytokines 112 . Although Ly6C hi CD11b + F4/80 + and Ly6C low CD11b + F4/80 + splenic populations are increased in myeloid cell-specific Casp8-knockout mice, these cells do not sufficiently induce antigenspecific T-cell proliferation 112 . In vitro studies revealed that caspase 8-deficient macrophages are prone to caspaseindependent death in response to death receptor ligation, yet caspase 8-deficient myeloid cell populations are not predisposed to unchecked survival 112 . Indeed, analysis of mixed bone marrow chimeric mice demonstrates that caspase 8 deficiency does not enable myeloid populations to preferentially expand 112 . Despite the relatively mild inflammatory phenotype observed in myeloid cell-specific Casp8-knockout mice, caspase 8-deficient bone marrow-derived macrophages are hyper responsive to TLR activation (FIG. 2) 112 . Furthermore, myeloid cell-specific caspase 8 deficiency seems to enhance the response to TLR activation in vivo, as injection of TLR ligands into mutant mice upregulates the expression 112 . In addition, oral antibiotic treatment to remove a substantial amount of the gut microbiota prevents inflammatory disease phenotypes in young myeloid cell-specific Casp8-knockout mice (FIG. 2) 112 . These data suggest that gut microbiota contribute to this phenotype, potentially by providing endogenous TLR ligands to stimulate already hyperactivated myeloid cell populations. Moreover, caspase 8 controls the polarization of macrophages in response to M1-skewing media (which contains IFNγ and LPS), as demonstrated by the prevented formation of true M1 macrophages in Casp8-deficient mice (FIG. 3) 
112
. Another group evaluated caspase-8 deficiency in myeloid cells, yet these mice (LysM cre/cre Casp8 del/flox ) failed to generate caspase 8 deficiency in all myeloid cell populations or in vivo dysregulation of macrophage populations, presumably because of the cell-specific caspase 8 deletion construct 113 . Taken together, these studies implicate caspase 8 in the regulation of macrophage response to TLR activation and macrophage polarization. Furthermore, requirement of caspase 8 for macrophage polarization indicates that disrupted caspase 8 signalling in synovial macro phages might be a fundamental defect at the root of RA pathogenesis.
DC-specific deletion of caspase 8 in mice (CD11c cre Casp8 flox/flox mice) is sufficient to induce an aggressive SLE-like disease 114, 115 . In these mutant mice, DCs do not display a survival advantage, indicating that defective DC apoptosis is not the underlying cause of the observed inflammation 114 . Furthermore, caspase 8-deficient bone marrow-derived DCs are hyperresponsive to TLR activation, and caspase 8-deficient splenic DCs upregulate co-stimulatory molecules in response to administration of TLR agonists in vivo (FIG. 4) 114 . Similar to patients with SLE, DC-specific Casp8-knockout mice present an interferon signature (FIG. 4) that might reflect a higher activity of IRFs -a family of transcription factors known to have a role in the production of type 1 interferons 114 . Although caspase 8 has been shown to process IRF3 for degradation 111 , and Casp8-deficient bone marrow-derived DCs constitutively express elevated IRF3 114 , deletion of Irf3 in DC-specific Casp8-knockout mice did not prevent, but instead exacerbated, SLE-like disease 114 . Moreover, deletion of IRF7, a redundant homologue of IRF3, neither prevented nor exacerbated disease in these mutant mice 114 . As in DC-specific FADD-deficient mice, deletion of MYD88 prevents SLE-like disease in DC-specific Casp8-knockout mice (FIG. 4) , although oral antibiotic treatment is ineffective at diminishing inflammation in these mutants 114 . These data demonstrate that caspase 8 in DCs maintains tolerance through MYD88 signalling, independently of cell death and IRF3 or IRF7 114 . Although caspase 8 can regulate multiple functions in macrophages and DCs, future studies are needed to determine the direct impact of these functions on the onset and progression of arthritis as well as RA susceptibility.
Intrinsic pathway of apoptosis
The intrinsic pathway of apoptosis is regulated by the BCL-2 protein family, which is divided into antiapoptotic and pro-apoptotic members 116 
(TABLES 2,3).
The pro-apoptotic family is divided into two additional categories: multi-BCL-2 homology (BH) domain proteins and BCL-2 homology region 3 (BH3)-only domain proteins. The prevailing view is that the BH3-only proteins either activate the multi-BH domain pro-apoptotic proteins or sequester BCL-2 anti-apoptotic proteins to induce apoptosis 116 . Alternatively, BCL-2 pro-apoptotic proteins might bind and prevent the BH3-only domain proteins from activating the apoptotic cascade 116 . The fact that not all BH3-only domain proteins bind to all BCL-2 anti-apoptotic proteins adds a further level of complexity. BIM, BID and PUMA (also known as BCL-2-like protein 11, BH3-interacting domain death agonist and BCL-2-binding component 3, respectively) are the most promiscuous, as they equally bind to all BCL-2 anti-apoptotic proteins, whereas BAD and NOXA only bind to some BCL-2 anti-apoptotic members 117 . This specificity correlates with their ability to induce apoptosis 117 . Peptides containing the BH3 domains of BIM, BID or PUMA are sufficient to induce apoptosis in whole cells and can disrupt the membrane potential in isolated mitochondria 117 . By contrast, BH3-only proteins are unable to induce apoptosis and require additional unknown signals to activate the apoptotic cascade; thus, they are considered 'sensitizers' of apoptosis 117 . Once the apoptotic signalling is initiated, BAK and BAX form homodimers and heterodimers at the mitochondrial outer membrane, causing the release of inner mito chondrial proteins such as cytochrome c 117, 118 . Subsequently, cytochrome c binds to apoptotic proteaseactivating factor 1 (APAF1) and caspase 9 forming the apoptosome, which activates downstream caspases (such as caspase 3 and caspase 7) that cleave numerous proteins and degrade DNA 117, 118 .
Intrinsic pathway of apoptosis in RA. The BCL-2 protein family has been extensively studied over the past decade in synovial tissue from patients with RA. The vast majority of the work has focused on whole-tissue expression rather than a particular cell type. For example, individual cell populations expressing BCL-2, BCLXL or MCL1 have not been examined in a systematic and/or quantitative manner. BCL-2 expression is increased in patients with RA compared with patients with osteoarthritis, and its concentration correlates with disease activity 119 . Similarly, BCLXL is highly expressed in the RA synovium and correlates with the number of inflammatory cells in the synovial sublining 120 . MCL1 expression is increased in RA synovial fluid macrophages compared with normal macrophages differentiated from peripheral blood monocytes in vitro 121 ; however, MCL1 expression in the synovial tissue is enhanced in the synovial lining and sublining, particularly in the synovial fibroblast population 122 . Similarly, PUMA is detected in the synovial sublining and is expressed at high levels in cultured RA synovial fibroblasts 123 . Furthermore, BAX expression is reduced in RA synovial tissue as compared with normal synovial tissue 124 , although individual synovial cell types expressing BAX are unknown. By contrast, only the expression of BIM has been shown to be reduced in the synovial lining, particularly within the macrophage population 125 . Taken together, these data suggest that in the RA synovium, anti-apoptotic BCL-2 proteins are highly expressed, whereas expression of pro-apoptotic proteins is reduced. Future studies will be required to identify the individual populations of cells expressing BCL-2 proteins in the RA synovium.
Intrinsic pathway of apoptosis in experimental arthritis.
Genetically modified mice have been utilized to understand the role of BCL-2 protein family in the development and sustainment of RA-like disease (TABLE 1) . Initial studies in CIA mouse models focused on the overexpression of BCL-2 and BCLXL in lymphocytes. Results showed that although overexpression of BCLXL in B cells exacerbates CIA 126 , in T cells it attenuates the development of arthritis, potentially through their resistance to apoptosis, delayed cell cycle progression and inhibition of IFNγ production in response to type II collagen challenge 127 . Similarly, overexpression of BCL-2 in all haematopoietic cells reduces the development of CIA, potentially by resulting in decreased production of antibodies against type II collagen
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. Although treatment with the BCL-2 antagonist ABT-737, which acts as a BAD mimetic, has proved effective at inhibiting RA-like disease in CIA, other studies have questioned the therapeutic value of this inhibitor because of its toxicity 129, 130 . Loss of BID or BIM, but not BAK or BAX, results in increased severity of K/B×N serum transfer-induced arthritis 131, 132 . In arthritic mice lacking BID, secretion of CXCL1 (also known as KC) and IL-1β, as well as the number of macro phages, is increased, whereas the number of apoptotic cells in the synovium is decreased compared with wild-type mice 132 . Similarly, arthritic mice lacking BIM exhibit increased osteoclast activity, which is associated with enhanced bone destruction 131 . Furthermore, these mice have elevated pannus formation, which might be attributable to the lower numbers of apoptotic cells 131 . Additionally, in Bim −/− mice, expression of CXCL1 and IL-1β in the arthritic joints is increased, whereas serum TGFβ is decreased 131 . Treatment with a peptide mimetic corresponding to the BH3 domain of BIM was sufficient to prevent the onset of RA-like disease and to suppress established disease in mice 125 . This transactivator of transcription (TAT)-BH3 peptide preferentially affects myeloid cells and prevents their infiltration into the joint 125 . Moreover, treatment with the TAT-BH3 peptide does not result in negative systemic effects, as demonstrated by normal liver function and platelet numbers 125 . Overexpression of BCL-2 in haematopoietic cells reduces the development and severity of K/B×N serum transfer-induced arthritis in mice, potentially owing to an expansion of Ly6C low monocytes and increased expression of the inhibitory IgG receptor FcγRIIb in leukocytes 128 .
Thus, these data demonstrate that the BCL-2 protein family might an appropriate target for novel RA therapeutics. However, as only one study has directly examined the innate immune system in murine models of RA-like disease, cell-specific apoptotic roles for BCL-2 family members need to be further investigated in the context of experimental inflammatory arthritis.
Similar to members of the extrinsic apoptotic pathway, members of the intrinsic apoptotic pathway also possess non-apoptotic functions. None of the transgenic mice overexpressing BCL-2 proteins develop SLE-like disease. Moreover, mice globally deficient in BAX, BAK or BH3-only proteins also fail to develop SLE-like disease. By contrast, Bim −/− mice develop systemic autoimmunity that is associated with increased numbers of monocytes and macrophages 133, 134 . Thus, these data suggest that although BIM is considered promiscuous and capable of sequestering all anti-apoptotic proteins 135 , its role in autoimmunity does not match that of BCL-2 and BCLXL, as demonstrated by the fact that overexpression of anti-apoptotic proteins fails to induce autoimmunity [136] [137] [138] . These data also indicate that, in contrast to other BH3-only proteins, BIM has a substantial role in autoimmunity. Bim −/− macro phages display increased markers of activation and secrete elevated levels of IL-1β following thioglycollate elicitation or TLR ligation 125 . Although these macrophages have not been examined for their ability to process and present antigens to T cells, BIM-deficient DCs induce strong T-cell responses in OT-I and OT-II mice, which are transgenic for an ovalbumin-specific TCR 139 . Similar results were observed in mice that overexpress BCL-2 in DCs [140] [141] [142] ; however, unlike those cells 140 , Bim −/− DCs cause autoantibody production following adoptive cell transfer and LPS stimulation in control mice 139 . Furthermore, a 2011 study reported that loss of BID in macrophages has an inhibitory effect on the production of proinflammatory cytokines in response to ligands of nucleotide-binding oligo merization domain (NOD) proteins, but not those of TLR; this effect was independent of the BH3 domain 143 . These data suggest that, unlike other BH3-only proteins, BIM might have other functions beyond its role apoptosis.
Necroptotic pathway. Pathways of programmed cell death other than apoptosis have been identified in the past 5 years, including necroptosis 144 . The apoptotic pathway (described above) and the newly described necroptotic pathway are both essential for cell turnover, yet the underlying mechanisms differ and depend on the cytosolic milieu. Necroptosis is promoted by the receptor interacting serine/threonine-protein kinases 1 and 3 (RIPK1 and RIPK3), as well as the mixed lineage kinase domain-like protein (MLKL). When apoptosis is blocked, necroptosis can be triggered by TNF (a cytokine abundantly present at the sites of inflammation) or by other stimuli 19 , involving components of the extrinsic apoptotic pathway. The binding of TNF to its receptor TNFR1 at the cell surface triggers the recruitment of FADD. Subsequently, aggregation of FADD facilitates the recruitment of pro-caspase 8, which becomes active after dimerization. Active caspase 8 can either initiate the degradative phase of apoptosis or block necroptosis, depending on the availability of FLIP 135, 145 . Low levels of FLIP enable the formation of caspase 8 homodimers, and apoptosis ensues as described above 145 . Conversely, when present at sufficient levels, FLIP can be recruited by FADD to form a heterodimer with caspase 8; this complex not only prevents apoptosis, but also limits necroptosis by suppressing RIPK1-RIPK3 signalling 145 . Furthermore, in the absence of FADD or caspase 8, apoptosis is blocked; however, RIPK1-RIPK3 signalling would proceed unchecked, thus leading to nec roptosis 145 . Other caspase 8 death-independent functions have also been directly linked to RIPK activity. For example, TLR engagement provokes RIPK signalling independently of death receptor activation, leading to the formation of the ripoptosome -a complex containing similar proteins involved in necroptosis -or the necrosome (composed of FADD, caspase 8, FLIP and RIPK1) 146 . Ripoptosome-RIPK3 activity induces IL-1β production 147 , whereas caspase 8-RIPK signalling can regulate the NLRP3 inflammasome 115, 148, 149 . Because of the mounting death-independent functions assigned to molecules involved in the activation of the necrosome or ripoptosome pathways, these signalling mediators remain under intense investigation. Given that nec roptotic cells can promote inflammation resulting from the release of cytokines, DAMPs and pathogen-associated molecular patterns (PAMPs), the signalling mediators warrant examination in the context of the RA joint.
Whereas Ripk1 −/− mice die perinatally 150 , Ripk3
−/− mice show no gross defects in development 151 . Deletion of either Ripk1 or Ripk3 rescues embryonic lethality associated with the global knockout of FADD and Casp8 in mice, but not the global knockout of FLIP 145, 152, 153 . Similarly, conditional loss of RIPK3 in myeloid cells and DCs rescues the phenotypes associated with FADD deficiency in knockout mice 92, 93 . In addition, symptoms of systemic inflammation in myeloid cell-specific caspase 8-deficient mice are ameliorated by deletion of Ripk3 (FIG. 2) 
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. However, RIPK3 is not involved in the aggressive SLE-like disease in DC-specific caspase 8-deficient mice 114, 115 . In vitro studies also implicate RIPK1 in the hyper-activation of bone marrow-derived macrophages and bone marrow-derived DCs from myeloid cellspecific and DC-specific Casp8-deficient mice following TLR activation 112, 114 (FIG. 2 and FIG. 4) . These data suggest that uncontrolled RIPK1 activity might contribute to the SLE-like disease of mutant mice, although the role of this protein in inflammatory arthritis remains unresolved. A 2015 report showed that Ripk3 −/− mice display a more rapid resolution of K/B×N arthritis compared with control mice, whereas mice deficient for MLKL respond normally to the induction of serum-induced arthritis 154 . These results indicate that the action of necroptotic mediators in macrophage and DC populations should be examined in the context of RA.
Inhibitors of apoptosis.
Inhibitors of apoptosis proteins (IAPs) are also linked to RA. IAPs can regulate apoptosis by directly binding to and preventing the downstream effector functions of caspase 3, caspase 7 and caspase 9, thereby blocking the assembly of caspase 8 and caspase 10 155, 156 . In response to a pro-apoptotic stimulus, second mitochondria-derived activator of caspases (SMAC, also known as DIABLO) can be liberated from the mitochondria and translocate into the cytoplasm to block the anti-apoptotic activity of IAPs 157, 158 . A number of compounds have been designed to mimic the structure of these molecules. Smac mimetics bind specifically to three IAPs, including E3 ubiquitin-protein ligase XIAP, baculoviral IAP repeat-containing protein 2 (also known as cellular IAP1(cIAP1)) and baculoviral IAP repeat-containing protein 3 (also known as cellular IAP2 (cIAP2)) 155 . One such SMAC mimetic downregulates XIAP, cIAP1 and cIAP2 and can induce cell death in apoptosis-resistant RA synovial fibroblasts, thereby implicating Smac as a local therapeutic for RA 155 . Studies show that mice with myeloid cell-specific deletion of cIAP1 and either global knockout of cIAP2 Autophagy. Autophagy is a survival strategy whereby a cell, when deprived of nutrients or subjected to other stressors, can degrade dysfunctional and/or unneeded organelles using its own lysosomal machinery. Studies in the past 5 years suggest that the impaired apoptosis observed in RA synovial tissues might be the result of increased autophagy [159] [160] [161] . In cultured RA synovial fibroblasts, induction of autophagy and low expression of DNA damage-inducible transcript 3 protein (also known as CHOP) protects these cells from death by limiting the endoplasmic reticulum (ER) stress response 159 . Furthermore, whole RA synovial tissue is characterized by higher expression of beclin 1 (a protein that stimulates the initiation of autophagy) and microtubule-associated proteins 1A/1B light chain 3B (also known as LC3 B; a component of autophagosomes, double-membrane vesicles responsible for delivering cytoplasmic material to lysosomes), which coincides with a deficiency in the beclin 1-targeting microRNA miR-30a 160 . Autophagy induction by proteasome inhibition or ER stress is more pronounced in RA synovial fibroblasts than in those found in osteoarthritis joints 161 . Furthermore, the autophagy pathway not only promotes cell death in the context of ER stress, but can also protect against cell death caused by proteasome inhibition 161 . Thus, autophagy has both cytoprotective and cytodestructive roles in RA synovial fibroblasts, and can therefore function as an adaptor between cell death and survival [161] [162] [163] . Methotrexate, the most widely used DMARD, suppresses proliferation of lymphocytes and macrophages, but has a limited pro-apoptotic effect in RA synovial fibroblasts [164] [165] [166] . Resistance to methotrexate treatment is caused, in part, by the induction of autophagy 167 . In contrast to RA synovial fibroblasts, RA T cells are characterized by reduced autophagy, and therefore are prone to undergo apoptosis 168 . Exaggerated T-cell apoptosis leads to chronic T-cell loss and development of lymphopenia, which has been proposed as a risk factor for autoimmunity 168 . 
Citrullination
The conversion of the amino acid arginine within a protein to the amino acid citrulline.
Studies in mice also suggest that autophagy is linked to RA pathogenesis. In antigen-presenting cells such as macrophages and DCs, autophagy is a key cellular process responsible for the citrullination of antigens to be presented at the cell surface in the context of MHC 169 . Autoantibodies to citrullinated proteins are found in patients with RA and correlate with disease severity 170 . Members of the autophagy signalling pathways, including ubiquitin-like modifier-activating enzyme ATG7 (a protein essential for the elongation of the phagophore -also known as isolation membrane -during autophagy) and beclin 1, are upregulated in osteoclasts of patients with RA 171 . In mice overexpressing human TNF, RA-like phenotypes, including osteoclastogenesis and destructive arthritis, occur spontaneously. Transplantation of bone marrow cells from myeloid cell-specific Atg7-knockout mice into mice overexpressing human TNF reduces osteoclast numbers and protects mice from TNF-induced bone erosion, proteoglycan loss and chondrocyte death, but not inflammation 171, 172 . Data obtained from these mutant mice implicate osteoclast autophagy in the pathogenesis of RA; nonetheless, given that myeloid cell-specific Atg7 deletion occurs not only in osteoclasts but also in circulating neutrophils and monocytes, autophagy of monocyte-derived macrophages that accumulate in the RA joint might also be involved. A 2015 study showed that the anti-diabetic drug metformin, previously reported to stimulate autophagy, can mitigate inflammation in K/B×N serum transfer-induced arthritis 173 . In vitro, metformin stimulates AMP-activated protein kinase (AMPK) activity in macrophages during arthritis. This stimulation inhibits mTOR signalling, thereby correcting the impaired autophagic flux associated with experimental arthritis and suppressing NF-κB-mediated signalling through degradation of IκB kinase (IKK) 173 . These data, in addition to the risk polymorphisms in autophagy signalling mediators identified in patients with RA and SLE, implicate autophagy in the pathogenesis of autoimmune rheumatic diseases [174] [175] [176] . Therefore, the role of autophagy, especially in RA synovial macrophage and DC populations, merits further investigation.
Conclusions
Great strides have been made in the past decade in the attempt to dissect the role of cell death-associated signalling molecules in the pathogenesis of RA. Phagocytosis of dying cells by professional phagocytes, such as macrophages and DCs, is crucial to maintain tissue homeostasis; however, when this process goes awry, inflammation and exposure to self-antigens might occur, leading to the onset of autoimmunity. In the context of the joint, phagocytosis of infiltrating short-lived cells, such as neutrophils, might signal macrophages to adopt a wound healing phenotype, thus implicating synovial macrophages in the control of inflammation. However, should synovial macrophages or DCs present with defects in signalling mediators and/or inhibitors of cell death pathways, detrimental outcomes are predicted to occur within both the homeostatic and RA joint. As these signalling mediators and/or inhibitors of cell death pathways can also maintain functions beyond their involvement in cell death, further investigation is warranted to fully characterize their roles within synovial phagocyte populations for discovery of potentially novel therapeutic targets. 
